Pharmaceutical R&D in an era of managed healthcare: using integrative teams to produce enduring competitive advantage

Authors: Lant, Theresa K.; Eisner, Alan B.

Source: International Journal of Technology Management, Volume 15, Numbers 3-4, August 1998 , pp. 299-321(23)

Buy & download fulltext article:

Price: $44.11 plus tax (Refund Policy)

Abstract:

Medical technology organisations are faced with greater performance pressure in the new managed healthcare environment. In particular, pharmaceutical research and development (R&D) organisations are expected to create new and useful therapeutic treatments with greater resource constraints than ever previously experienced. We explore how pharmaceutical R&D organisations are changing the way they manage the research process in response to changing organisational and environmental constraints. This paper suggests an integrative team approach to the efficient and effective management of pharmaceutical R&D in a managed healthcare environment. We view integrative teams as an important means of increasing R&D productivity and producing competitive advantage.

Keywords: MANAGEMENT AND BUSINESS; Policy and Organisational Management; Technology Management

Document Type: Research article

DOI: http://dx.doi.org/10.1504/IJTM.1998.002616

Affiliations: 1: Management Department, The Stern School of Business, New York University, 44 W. 4th Street, New York, NY 10012, USA. Management and Management Science Department, Lubin School of Business, Pace University, 861 Bedford Road, Pleasantville, NY 1057

Publication date: 1998-08-01

More about this publication?